← Back to all trials
Completed
NCT07927335
ACEs, CBT-i, and Cardiovascular Health
Conditions: Adverse Childhood Experiences, Sleep Disruption, Vascular Dysfunction, Endothelial Function (FMD)
Sex: All
Ages: 18 Years – 29 Years
Healthy volunteers: Yes
Phase: NA
Enrollment: 16
Sponsor: University of Iowa
Location: Integrative Laboratory of Applied Physiology and Lifestyle Medicine Iowa City Iowa
Summary
Our accumulating evidence indicates that young adults that have been exposed to Adverse Childhood Experiences (ACEs) display both impaired vascular function, poorer cardiometabolic health, and poor sleep. Our data indicate that sleep impairments may mediate the link between ACEs and vascular and metabolic dysfunction. The primary purpose of this project is to determine if cognitive behavioral therapy for insomnia (CBT-i) is feasible for improving sleep in young adults who have been exposed to ACEs and who have poor sleep. Secondarily, we will collect preliminary efficacy data to determine whether CBT-i can improve vascular and cardiometabolic health in this population, as well as perceived stress and anxiety.
Eligibility Criteria
Inclusion Criteria:
* Age 18-29 years, inclusive
-≥4 adverse childhood experiences on the \[CDC-Kaiser 10-item\] ACE questionnaire AND self-reported childhood stress ≥4 on a 0-5 rating scale
* Poor sleep, defined as a PSQI global score \>5 AND PSQI-derived habitual sleep efficiency \= 6 months for major depressive disorder or major anxiety disorders
* Willing and able to complete the intervention and all study procedures
Exclusion Criteria:
* Diagnosed cardiometabolic disease, including cardiovascular disease, hypertension, type 1 or type 2 diabetes, or chronic kidney disease
* Diagnosed sleep disorder (e.g., obstructive sleep apnea, insomnia disorder, narcolepsy, restless legs syndrome)
* Current shift work involving overnight hours
* Children living in the household
* Current use of tobacco or nicotine products, including e-cigarettes and vaping
* Daily alcohol consumption
* Habitual caffeine intake \>5 mg/kg/day
Source: ClinicalTrials.gov (NCT07927335). StuddyBuddy aggregates publicly available trial information.